Full Coverage

Aveo completes enrollment in Phase II renal cell carcinoma trial

pharmaceutical-business-review.com
May 30, 2008
        
Story Timeline:  189 days

Aveo Pharmaceuticals has completed enrollment in its 200-patient Phase II clinical trial of AV-951 in patients with metastatic renal cell carcinoma. This placebo-controlled, randomized discontinuation trial is assessing the safety... [read full story]                    

Add Comment
Latest article on this story:

AVEO Pharmaceuticals Completes Enrollment In Phase 2 Clinical Trial Of AV-951 In Patients With...

 medicalnewstoday.com Jun 1, 2008
First article on this story:

AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with...

 ad-hoc-news.de May 29, 2008
Selected publications with coverage of this story:
pharmaceutical-business-review.com redorbit.com medicalnewstoday.com euroinvestor.co.uk ad-hoc-news.de pharmiweb.co.uk finanznachrichten.de
RELATED
Found 4 documents:
                   

AVEO Pharmaceuticals Completes Enrollment In Phase 2 Clinical Trial Of AV-951 In Patients With...

medicalnewstoday.com
Jun 1, 2008
        

AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that they have completed enrollment in...

Aveo Completes Enrollment in Phase II Renal Cell Carcinoma Trial

redorbit.com
May 30, 2008
        

Posted on: Friday, 30 May 2008, 06:00 CDT Aveo Pharmaceuticals has completed enrollment in its 200-patient Phase II clinical trial of AV-951 in patients with metastatic renal cell carcinoma. This placebo-controlled, randomized...

AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with...

finanznachrichten.de
May 29, 2008
        

AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that they have completed enrollment in their 200-patient Phase 2 clinical trial of AV-951 in patients with...

AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with...

ad-hoc-news.de
May 29, 2008
        

AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with Metastatic Renal Cell Carcinoma AVEO Pharmaceuticals Completes Enrollment in Phase 2 Clinical Trial of AV-951 in Patients with Metastatic Renal Cell CarcinomaCAMBRIDGE, Mass.MA-AVEO-PHARMACEUTICALS...